Merck Partners with Jiangsu Hengrui Pharmaceuticals for HRS-5346, Expanding its Cardio-Metabolic Portfolio
Shots: Merck has entered into an exclusive license agreement with Jiangsu Hengrui...
Alumis and Kaken Pharmaceutical Enter Collaboration & Licencing Deal for ESK-001’s Development & Commercialization in Japan
Shots: Alumis & Kaken have partnered to develop, manufacture, & market ESK...
The United Laboratories (TUL) and Novo Nordisk Enter Exclusive License Agreement for UBT251
Shots: TUL has granted Novo Nordisk exclusive global rights to develop, manufactur...
Harbour BioMed & AstraZeneca Partner to Develop Multi-Specific Antibodies across Various Therapeutic Areas
Shots: Harbour & AstraZeneca (AZ) have entered into a global strategic collabo...
AstraZeneca Collaborates with Syneron Bio to Develop Macrocyclic Peptides for Chronic Diseases
Shots: Syneron Bio & AstraZeneca have entered into a strategic collaboration t...
Sanofi to Acquire Dren Bio’s Bispecific Antibody DR-0201 for ~$1.9B
Shots: Sanofi has entered into a definitive agreement with Dren Bio to acquire DR-...
